Get started
Author

Marc J.T.M. Mol

Observed names: M J Mol, M J T M Mol, M. J. T. M. MOL, M. J. T. M. Mol, M. J. Th. Mol, M. J.T.M. Mol, M.J. Mol, M.J.T.M. Mol, Marc J Mol, Marc J T M Mol, Marc J. T. M. Mol, Marc J.T.M Mol, Marc JTM. Mol, Marc Mol
Observed institutions: Leiden University, Radboud University Nijmegen, Netherlands Organisation for Applied Scientific Research, Radboud University Medical Center, University of California San Diego, Canisius-Wilhelmina Ziekenhuis
OpenAlex ID: A5113556185
Effects of Synvinolin (mk-733) on Plasma Lipids in Familial Hypercholesterolaemia
1986 · M.J.T.M. Mol, J.A.Gevers Leuven, et al. · The Lancet · 157
Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment
1997 · Marc J.T.M Mol, Yolanda B de Rijke, et al. · Atherosclerosis · 130
Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase
1995 · David J. Benz, Marc Mol, et al. · Journal of Biological Chemistry · 107
PDF
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
1996 · B J van Vlijmen, H B van 't Hof, et al. · Journal of Clinical Investigation · 91
PDF
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia
1990 · Peter De Kniiff, Anton F.H. Stalenhoef, et al. · Atherosclerosis · 83
Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia
1988 · Marc J.T.M. Mol, D. Willem Erkelens, et al. · Atherosclerosis · 79
Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial
2017 · Juliane Menting, Cees J Tack, et al. · The Lancet Diabetes & Endocrinology · 57
PDF
Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1
1996 · Miek C. Jong, Vivian E.H. Dahlmans, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 57
Efficacy and tolerability of simvastatin (MK-733)
1989 · Anton F.H. Stalenhoef, Marc J.T.M. Mol, et al. · The American Journal of Medicine · 39
Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study
2012 · Richard Engbersen, Niels P Riksen, et al. · Cardiovascular Diabetology · 29
PDF
Effects of Inhibition of Cholesterol Synthesis by Simvastatin on the Production of Adrenocortical Steroid Hormones and Acth
1989 · M. J. T. M. MOL, A. F. H. STALENHOEF, et al. · Clinical Endocrinology · 29
An automated computerized method using Finapres for measuring cardiovascular reflexes
1992 · P. M. Netten, J. M. M. Boots, et al. · Clinical Science · 23
Clinical Experience with Simvastatin Compared with Cholestyramine
1988 · D. W. Erkelens, M. G.A. Baggen, et al. · Drugs · 23
Some metabolic characteristics of low-density lipoprotein subfractions, LDL-1 and LDL-2: in vitro and in vivo studies
1988 · Dorine W. Swinkels, Pierre N.M. Demacker, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 22
Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor
1996 · R K Tangirala, M J Mol, et al. · Journal of Lipid Research · 20
A web-based cognitive behaviour therapy for chronic fatigue in type 1 diabetes (Dia-Fit): study protocol for a randomised controlled trial
2015 · Juliane Menting, Stephanie Nikolaus, et al. · Trials · 17
PDF
HMG CoA reductase inhibitors
1993 · Marc J.T.M. Mol, Anton F.H. Stalenhoef · Current Opinion in Lipidology · 15
Long‐term effects of simvastatin in familial dysbetalipoproteinaemia
1991 · P. M. J. STUYT, M. J. T. M. MOL, et al. · Journal of Internal Medicine · 14
Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol
1990 · P N M Demacker, M J T M Mol, et al. · Biochemical Journal · 14
PDF
Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
1990 · P M Stuyt, M J Mol, et al. · PubMed · 12
The role of modification of lipoproteins and of the immune system in early atherogenesis.
1993 · M J Mol, P N Demacker, et al. · PubMed · 11
Chondrosarcoma coexistent with dermatomyositis
1986 · M. J. Th. Mol, A. F. H. Stalenhoef, et al. · Arthritis & Rheumatism · 10
Adrenocortical function in patients on simvastatin
1990 · M.J.T.M. Mol, A.F.H. Stalenhoef · The Lancet · 9
The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
1990 · M J Mol, P M Stuyt, et al. · PubMed · 7
Chronic active Epstein-Barr virus infection in an adult with no detectable immune deficiency.
2003 · M de Boer, M J T M Mol, et al. · PubMed · 6
Works count: 36
Citation count: 1,079
H-index: 16
I10-index: 22
Year
Topic
Type